These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18614790)

  • 1. VEGF inhibition and renal thrombotic microangiopathy.
    Katavetin P; Katavetin P
    N Engl J Med; 2008 Jul; 359(2):205-6; author reply 206-7. PubMed ID: 18614790
    [No Abstract]   [Full Text] [Related]  

  • 2. VEGF inhibition and renal thrombotic microangiopathy.
    Nochy D; Lefaucheur C; Hill G
    N Engl J Med; 2008 Jul; 359(2):206; author reply 206-7. PubMed ID: 18618951
    [No Abstract]   [Full Text] [Related]  

  • 3. VEGF inhibition and renal thrombotic microangiopathy.
    Eremina V; Jefferson JA; Kowalewska J; Hochster H; Haas M; Weisstuch J; Richardson C; Kopp JB; Kabir MG; Backx PH; Gerber HP; Ferrara N; Barisoni L; Alpers CE; Quaggin SE
    N Engl J Med; 2008 Mar; 358(11):1129-36. PubMed ID: 18337603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.
    Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N
    Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy and anti-VEGF agents.
    Izzedine H; Brocheriou I; Deray G; Rixe O
    Nephrol Dial Transplant; 2007 May; 22(5):1481-2. PubMed ID: 17189283
    [No Abstract]   [Full Text] [Related]  

  • 6. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
    Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
    Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
    Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
    J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
    Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
    Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy.
    Burke GA; McGraw ME; MacIver AG
    Pediatr Nephrol; 1999 Sep; 13(7):564-6. PubMed ID: 10460501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma.
    Frangié C; Lefaucheur C; Medioni J; Jacquot C; Hill GS; Nochy D
    Lancet Oncol; 2007 Feb; 8(2):177-8. PubMed ID: 17267332
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
    Kim YG; Suga SI; Kang DH; Jefferson JA; Mazzali M; Gordon KL; Matsui K; Breiteneder-Geleff S; Shankland SJ; Hughes J; Kerjaschki D; Schreiner GF; Johnson RJ
    Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life and Death of Podocytes: Not Only a Matter of Vascular Endothelial Growth Factor.
    Novelli R; Benigni A
    Am J Nephrol; 2016; 43(2):71-3. PubMed ID: 26930245
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
    Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
    Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.
    Bollée G; Patey N; Cazajous G; Robert C; Goujon JM; Fakhouri F; Bruneval P; Noël LH; Knebelmann B
    Nephrol Dial Transplant; 2009 Feb; 24(2):682-5. PubMed ID: 19054798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
    Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
    Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.
    Hohenstein B; Hausknecht B; Boehmer K; Riess R; Brekken RA; Hugo CP
    Kidney Int; 2006 May; 69(9):1654-61. PubMed ID: 16541023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional symbiosis between endothelium and epithelial cells in glomeruli.
    Hirschberg R; Wang S; Mitu GM
    Cell Tissue Res; 2008 Feb; 331(2):485-93. PubMed ID: 17999087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
    Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein.
    Cui TG; Foster RR; Saleem M; Mathieson PW; Gillatt DA; Bates DO; Harper SJ
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F767-73. PubMed ID: 14644752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes.
    Datta K; Li J; Karumanchi SA; Wang E; Rondeau E; Mukhopadhyay D
    Kidney Int; 2004 Oct; 66(4):1471-8. PubMed ID: 15458440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.